HAQQ CHRISTOPHER (See Remarks) received a stock award from ELICIO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001601485-26-000002
Officer· See Remarks
Since Feb 2026
+76.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
76.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.40K
Price / share
—
Trade value
—
% of position
79.4%
2/2/2026
31.98K→57.38K
Total
Net shares
+25.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +25.40K | — | — | 79.4% | 31.98K | 57.38K |
| Total | +25.40K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50.90K shares
Shares
+50.90K
Strike price
8.10
Held after
50.90K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50.90K shares | 2/2/2026 | A · Award | +50.90K | 8.10 | — | 50.90K |